Charles River Laboratories Hits Day Low of $165.60 Amid Price Pressure

robot
Abstract generation in progress

Charles River Laboratories International, Inc. experienced a significant stock decline of 9.23% to an intraday low of $165.60, contrasting sharply with the S&P 500’s modest decrease. Over the past year, the company has underperformed the broader market, with a return of 0.45% compared to the S&P 500’s 14.11%, and its net profit for the first half of the year fell by 37.49%. The company’s market capitalization is USD 7,503 million, placing it as a small-cap entity within its industry.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin